HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David C Kem Selected Research

Muscarinic M2 Receptor

1/2016β1-Adrenergic and M2 Muscarinic Autoantibodies and Thyroid Hormone Facilitate Induction of Atrial Fibrillation in Male Rabbits.
6/2015Activating autoantibodies to the β1/2-adrenergic and M2 muscarinic receptors associate with atrial tachyarrhythmias in patients with hyperthyroidism.
5/2011Opposing cardiac effects of autoantibody activation of β-adrenergic and M2 muscarinic receptors in cardiac-related diseases.
9/2009Activating autoantibodies to the beta-1 adrenergic and m2 muscarinic receptors facilitate atrial fibrillation in patients with Graves' hyperthyroidism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David C Kem Research Topics

Disease

12Tachycardia (Tachyarrhythmias)
10/2019 - 03/2008
6Cardiac Arrhythmias (Arrythmia)
12/2015 - 11/2005
5Sinus Tachycardia
12/2015 - 03/2013
5Myocardial Infarction
01/2010 - 02/2005
4Postural Orthostatic Tachycardia Syndrome
12/2019 - 07/2017
4Atrial Fibrillation
01/2016 - 09/2009
4Hyperaldosteronism (Conn Syndrome)
10/2015 - 04/2002
4Hypertension (High Blood Pressure)
04/2015 - 04/2002
4Infarction (Infarctions)
03/2008 - 02/2005
3Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
01/2021 - 08/2020
3Hyperthyroidism
01/2016 - 09/2009
3Graves Disease (Basedow Disease)
01/2016 - 08/2014
3Hyperplasia
01/2015 - 04/2002
3Adenoma (Adenomas)
01/2015 - 04/2002
3Orthostatic Hypotension (Postural Hypotension)
10/2013 - 01/2012
3Cardiomyopathies (Cardiomyopathy)
05/2011 - 09/2008
3Heart Diseases (Heart Disease)
05/2011 - 09/2008
3Ventricular Tachycardia
03/2008 - 02/2005
2Obesity
01/2021 - 03/2007
2Insulin Resistance
01/2021 - 03/2007
2Vasovagal Syncope
01/2018 - 07/2017
2Myocarditis (Carditis)
06/2016 - 09/2008
2Ischemia
03/2008 - 11/2005
1Dizziness (Lightheadedness)
07/2017
1Heart Failure
06/2016
1Goiter
06/2015
1Subacute Thyroiditis (Thyroiditis, De Quervain)
06/2015
1Carcinoma (Carcinomatosis)
05/2014
1Cardiovascular Diseases (Cardiovascular Disease)
10/2013
1Inflammation (Inflammations)
04/2009
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
09/2008
1Cushing Syndrome
03/2007
1Infections
03/2007
1Critical Illness (Critically Ill)
03/2007
1Persistent Infection
03/2007
1Sepsis (Septicemia)
03/2007
1Hyperglycemia
02/2007

Drug/Important Bio-Agent (IBA)

24AutoantibodiesIBA
01/2021 - 09/2008
9Adrenergic Agents (Adrenergic Drugs)IBA
12/2019 - 03/2009
6Peptides (Polypeptides)IBA
10/2019 - 09/2008
5Adrenergic Receptors (Adrenergic Receptor)IBA
12/2019 - 05/2011
5Immunoglobulin G (IgG)IBA
01/2018 - 09/2008
4LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA
01/2021 - 08/2020
4LigandsIBA
10/2019 - 06/2016
4AntibodiesIBA
01/2016 - 09/2008
4Muscarinic M2 ReceptorIBA
01/2016 - 09/2009
4Acetylcholine (Acetylcholine Chloride)FDA Link
12/2015 - 07/2006
4Proteasome Endopeptidase Complex (Proteasome)IBA
01/2010 - 11/2005
3ReninIBA
01/2018 - 04/2002
3Type 1 Angiotensin ReceptorIBA
01/2018 - 05/2014
3AldosteroneIBA
01/2015 - 04/2002
3Proteasome InhibitorsIBA
04/2009 - 11/2005
3Isoproterenol (Isoprenaline)FDA LinkGeneric
03/2008 - 11/2005
2Cardiac MyosinsIBA
06/2016 - 09/2008
2Thyroid HormonesIBA
01/2016 - 08/2014
2Norepinephrine (Noradrenaline)FDA LinkGeneric
02/2014 - 07/2006
2Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
01/2012 - 03/2009
2beta Adrenergic ReceptorsIBA
09/2008 - 02/2005
2Bortezomib (Velcade)FDA Link
03/2008 - 11/2005
1Hormones (Hormone)IBA
01/2021
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
12/2020
1Neutralizing AntibodiesIBA
10/2019
1AngiotensinsIBA
01/2018
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
06/2016
1Interleukin-6 (Interleukin 6)IBA
06/2016
1Interleukin-17 (Interleukin 17)IBA
06/2016
1Interleukin-23 (Interleukin 23)IBA
06/2016
1CytokinesIBA
06/2016
1Cholinergic Agents (Cholinergics)IBA
01/2016
1PeptidomimeticsIBA
12/2015
1Angiotensin Receptors (Angiotensin II Receptor)IBA
04/2015
1EnzymesIBA
01/2015
1ImmunosorbentsIBA
01/2015
1Monoclonal AntibodiesIBA
10/2013
1Vasodilator Agents (Vasodilators)IBA
02/2012
1Muscarinic M3 ReceptorIBA
02/2012
1hydroxide ionIBA
01/2012
1beta-1 Adrenergic Receptors (beta 1 Adrenergic Receptor)IBA
09/2009
1AtropineFDA LinkGeneric
09/2009
1Nadolol (Corgard)FDA LinkGeneric
09/2009
1UbiquitinIBA
04/2009
1Proteins (Proteins, Gene)FDA Link
04/2009
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
09/2008
1EpitopesIBA
09/2008
1AutoantigensIBA
09/2008
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
03/2008
1Anti-Bacterial Agents (Antibiotics)IBA
03/2007
1Hydrocortisone (Cortisol)FDA LinkGeneric
03/2007
1GlucocorticoidsIBA
03/2007
1NADH oxidaseIBA
02/2007
1Adrenergic beta-Agonists (beta-Adrenergic Agonists)IBA
07/2006
1CatecholaminesIBA
07/2006
1GTP-Binding Proteins (G-Protein)IBA
11/2005
1Phosphotransferases (Kinase)IBA
11/2005

Therapy/Procedure

4Ligation
03/2008 - 02/2005
1Injections
10/2019
1Intravenous Infusions
02/2014
1Gastrostomy
03/2007
1Therapeutics
03/2007
1Gastroplasty (Vertical-Banded Gastroplasty)
03/2007